Cabo Verde vs Sri Lanka: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Cabo Verde
0.0%
in 2025
Sri Lanka
0.0%
in 2025
Cabo Verde rank
165th
Sri Lanka rank
165th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Cabo Verde
- Sri Lanka
How they compare
Cabo Verde currently reports 0.0% against 0.0% in Sri Lanka, a difference of 0.0%.
Across all 18 years both countries report, Sri Lanka has been ahead every year.
Cabo Verde ranks 165th and Sri Lanka ranks 165th of 192 countries.
Head to head by decade
| Decade | Cabo Verde | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 0.0% | 0.0% | 0.0% | — |
| 2020s | 0.0% | 0.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Cabo Verde or Sri Lanka?
- Cabo Verde, at 0.0% against 0.0% in Sri Lanka as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Cabo Verde and Sri Lanka?
- 0.0%, with Cabo Verde ahead.
- How many years of comparable data are there for Cabo Verde and Sri Lanka?
- 18 years are reported by both, from 2008 to 2025.
- How do Cabo Verde and Sri Lanka rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Cabo Verde ranks 165th and Sri Lanka ranks 165th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.